Showing posts from October, 2015

Skechers Is No Sketch Comedy

Skechers Is No Sketch ComedyThe footwear speedster gets tripped up after a disappointing quarterRick Munarri/TheMotleyFool
Skechers(NYSE:SKX) executed a 3-for-1 stock split on Oct. 16. Every shareholder received two additional shares with the stock dropping to a third of its previous price. It was a zero-sum game. There was an unintentional 3-for-2 stock split a week later after the athletic footwear maker posted disappointing quarterly results, but investors didn't receive any more stock.

Yes, that's a lighthearted way to describe the gloomy aftermath following Skechers' rough quarter last week. The stock shed nearly a third of its value on Oct. 23 as growth decelerated, particularly at its domestic wholesale division that was rolling at a torrid pace before last week's letdown. The market had been spoiled in previous quarters.

The stock's 31.5% hit in a single day hurts -- that's no joking matter -- but it's hard for longtime investors to compla…

Zalemark Holding Co. Enters into a $1 Million Equity Purchase Agreement with Kodiak Capital Group, LLC

Zalemark Holding Co. Enters into a $1 Million Equity Purchase Agreement with Kodiak Capital Group, LLC
Los Angeles Ca./Accesswire/October 29, 2015
Zalemark Holding Co. (ZMRK), today announced that it has entered into a $1 million common stock purchase agreement with Kodiak Capital Group, LLC, a Newport Beach, California-based institutional investor. Zalemark is an award winning product design, development, manufacturing and distribution Company that develops and markets strategic jewelry brands such as, Crayola(R) Fine Jewelry, Mars(R) M&M's(R) Jewelry Brand, and Demeter(R) Fine Jewelry.

Zalemark has agreed to file a registration statement with the U.S. Securities and Exchange Commission covering the shares that may be issued to Kodiak under the terms of the common stock purchase agreement. After the SEC has declared the registration statement related to the transaction effective, Zalemark will have the right at its sole discretion over a period of one year to sell …

Aethlon Medical's Biofiltration Platform Tackles Everything from Ebola to Cancer: CEO James Joyce

Aethlon Medical's Biofiltration Platform Tackles Everything from Ebola to Cancer: CEO James Joyce Source: Gail Dutton of The Life Sciences Report  (10/28/15)
Aethlon Medical Inc. has pioneered a novel biofiltration platform that was used effectively against Ebola in 2014. Now this broad-spectrum platform is being tested against cancer and other life-threatening diseases. Aethlon CEO James "Jim" Joyce tells The Life Sciences Report how this device is helping transform modern healthcare.
The Life Sciences Report:Aethlon Medical Inc. (AEMD:NASDAQ) has developed a novel affinity biofiltration platform that removes disease-enabling particles from the bloodstream. How effective is it, and what makes it so effective?

James Joyce: At Aethlon Medical, we have established an expansive therapeutic platform that allows us to target a wide range of disease-promoting targets from the circulatory system. Our lead product, …

New Global Energy, Inc. is Aquaculture, Agriculture and Health & Wellness

New Global Energy is Focused on Acquiring High-Growth Assets in Aquaculture, Agriculture and Health & Wellness
New Global Energy, Inc. (NGEY), a public company focused on Aqua-Farming, Agriculture, and Health & Wellness, announced today that it has launched the tilapia spawning season at its farm in California's Coachella Valley with a record number of fish. New financing commitments from outside investors mean the coming year should prove to be record setting in terms of the number of sustainable fish grown and ultimately sold on the company's farm.
October is a critical month for planning and preparation since fish are seasonal and the new fingerlings will reach sufficient size from October through mid-November before temperature drops and will survive the mildly cold months of December and January. To help insure strong growth and because consumers increasingly demand healthy seafood, New Global feeds its fish a formula that is free of GMOs, antibiotics …

Walgreens Boots Alliance near deal to buy Rite Aid - WSJ

Walgreens Boots Alliance Near Deal to Buy Rite Aid - WSJ
Walgreens Boots Alliance near deal to buy Rite Aid - WSJReuters 9 mins ago Walgreens might buy Rite Aid and the stock is going nuclearBusiness Insider 17 mins ago Oct 27 (Reuters) - Drugstore operator Walgreens Boots Alliance Inc is in advanced talks to buy smaller rival Rite Aid Corp, the Wall Street Journal reported, citing people familiar with the matter. A deal is expected to be announced by Wednesday, the newspaper said. ( Rite Aid's shares were up 42 percent at $8.58. Walgreen's shares were up 4.2 percent at $93.46.

For more information: Disclaimer/ Disclosure: The Investors News Magazine is a third party publisher of news and research as well as creates original con…

NXT-ID, Inc. CEO Participating in Nasdaq Closing Bell Ceremony at Money 20/20

NXT-ID CEO Participating in Nasdaq Closing Bell at Money 20/20 Oxford, Connecticut, October 27, 2015 /PRNewswire/
NXT-ID, Inc. (NXTD) CEO Gino Pereira will be participating at the Nasdaq Closing Bell Ceremony today at Money 20/20. The ceremony will be streamed live and can be watched at or on television networks like CNBC, Fox Business or Bloomberg right at 4:00pm ET when the markets close.

NXT-ID, Inc. is demonstrating Wocket® Smart Wallet at the conference taking place at the Venetian Resort in Las Vegas, Nevada, October 25th to October 28th, 2015.

Wocket® is the smartest wallet you'll ever own. Designed to protect your identity and replace your old wallet, simply swipe and save your cards into Wocket once and they are immediately secured with pin and biometric voice print technology.  Without ever needing a smartphone, you can choose a card from the touch screen and Wocket programs its single, smart card (Wocket Card) to match y…

Ford misses on earnings, but the third quarter was its best ever in North America

Ford Misses On Earnings, Best Third Quarter Ever in North America By Matthew DeBord

Ford reported third quarter earnings on Tuesday.
They were slightly lower than analysts expectations. The company earned $0.45 per share. Analysts surveyed by Bloomberg were expecting $0.47 per share.

Revenue was $38.1 billion.
Higher taxes cut into Ford's profit for the quarter, Reuters reported.

Ford posted its best-ever quarter in North America, driven by sales of the F-150 full-size pickup, which was redesigned to use more lightweight aluminum in its construction.

There were issues with supply of the new truck that weighed on Ford sales earlier in the year. But in the third quarter, the car maker delivered over 207,000 pickups.
The auto market in the US has been booming. It's on a pace to see 17.5 million in new vehicle sales by December.
“We are delivering a breakthrough year,” said CEO Mark Fields in a statement.

For more information:…

Skechers Is Even More Attractive After Earnings Release

Skechers Is Even More Attractive After Earnings Release About: Skechers USA Inc. (SKX) SummaryThe global footwear industry will grow at a CAGR of 1.72% by 2020. Skechers expects to double its business over the next five years. Skechers GoWalk should keep adding more sales in the coming quarters.  While investors were enjoying the tech rally last week, the shoe stocks fell sharply after earnings announcement of Under Armour (NYSE:UA) and revenue miss of Skechers USA (NYSE:SKX). Although Skechers delivered strong earnings growth in the latest quarter, the soft sector outlook and thus ability to maintain a high double-digit top-line growth in a very competitive industry is now a major concern. Resultantly, Skechers plunged due to deteriorated investor sentiment and lost 31.50% value in one day.

Skechers share price is on a consistent rise since 2014 driven by strong top as well as bottom-line growth. After the crash, Skechers is still outperformer, up 75% YTD. Skec…

Brokerages Set Horizon Pharma PLC PT at $37.88 (NASDAQ:HZNP)

Brokerages Set Horizon Pharma PLC PT at $37.88 (NASDAQ:HZNP) Posted on October 25, 2015Horizon Pharma PLC (NASDAQ:HZNP) has received a consensus recommendation of “Buy” from the eleven research firms that are presently covering the stock, MarketBeat.Com reports. Two analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $37.88.

Shares of Horizon Pharma PLC (NASDAQ:HZNP) opened at 17.06 on Thursday. The stock’s market capitalization is $2.72 billion. The company’s 50-day moving average price is $22.48 and its 200 day moving average price is $29.63. Horizon Pharma PLC has a one year low of $11.87 and a one year high of $39.49.

Horizon Pharma PLC (NASDAQ:HZNP) last posted its quarterly earnings data on Friday, August 7th. The biopharmaceutical company reported $0.39 EPS for the quarter, topping the consensus estima…

Rocky Mountain High Brands, Inc. (RMHB) to Produce New 'Snow Flake' Graphic Cans This Week

Rocky Mountain High Brands to Produce New 'Snow Flake' Graphic Cans This Week Dallas, Tx.(Marketwired - Oct 26, 2015)Rocky Mountain High Brands, Inc. (OTC PINK: RMHB) announced today that the new 'Snow Flake' graphic cans of Rocky Mountain High beverages will be produced this week. The new graphic design is targeted specifically for large National / Regional retail accounts. The production run will also feature the introduction of a white can with colored mountains for all five (5) products, an infusion of 100 mg of hempseed extract in each can versus the previous 50 mg, the brand new 15 calorie Mango Energy drink sweetened with stevia and agave nectar, and now both energy drinks will contain 120 mg of caffeine.The New Mango Snow Flake Can is viewable on the Products
"A record breaking expanded production run of 96,000 cases will be produced this week," said Tom Shuman, President and CEO of RMHB. "The p…